Loading company…
Vascular Therapies develops treatments to improve vascular access for hemodialysis patients.
Founded in 2001 and based in Cresskill, US, Vascular Therapies develops vascular access treatments for hemodialysis patients. Its Sirogen™ implant delivers sirolimus locally at arteriovenous fistula sites. The company raised USD 23.96 mn in Series F funding on February 18, 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in